Related Experiment Video

Updated: Oct 2, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Nitrotriazole AK-2123 enhances mitomycin C activity in mice bearing multidrug-resistant tumors

S A Goncharova1, T A Rajewskaya, N P Konovalova

  • 1Institute of Problems of Chemical Physics, Russian Academy of Science, Chernogolovka, Moscow Region. sago@icp.ac.ru

Journal of Chemotherapy (Florence, Italy)
|January 25, 2002
PubMed

Insights

Nitrotriazole AK-2123 enhances chemotherapy sensitivity in multidrug-resistant (MDR) tumors. This radiosensitizer

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Multidrug-resistant (MDR) tumors often exhibit cross-resistance to mitomycin C (MMC), despite its DNA alkylation mechanism.
  • Understanding resistance mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the effect of nitrotriazole AK-2123 on mitomycin C sensitivity in MDR tumor strains.
  • To explore the correlation between AK-2123's modulatory effect and specific genetic factors in resistant tumors.

Main Methods:

  • Utilized previously characterized MDR strains of P388 mouse leukemia.
  • Assessed the sensitivity of these strains to mitomycin C in the presence of nitrotriazole AK-2123.
  • Correlated drug sensitivity modulation with the presence or absence of sorcin gene coamplification.

Main Results:

  • Nitrotriazole AK-2123 significantly enhanced mitomycin C sensitivity in MDR P388 mouse leukemia strains.
  • The observed enhancement was dependent on the initial sensitivity of the resistant tumors to mitomycin C.
  • Sensitivity modulation correlated with the coamplification status of the sorcin gene in the MDR amplicon.

Conclusions:

  • Nitrotriazole AK-2123 acts as a radiosensitizer that can overcome mitomycin C resistance in specific MDR tumors.
  • The drug's modulatory effect is linked to calcium transport mechanisms and sorcin gene expression.
  • AK-2123 does not possess intrinsic antitumor activity and does not affect the sensitivity of non-resistant parent tumors.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...